Amedeo Smart

Free Medical Literature Service


 

Amedeo

Peptic Ulcer

  Free Subscription

Articles published in
J Gastroenterol
    August 2021
  1. FUKUCHI T, Hirasawa K, Sato C, Makazu M, et al
    Potential roles of gastroesophageal reflux in patients with superficial esophageal squamous cell carcinoma without major causative risk factors.
    J Gastroenterol. 2021 Aug 23. pii: 10.1007/s00535-021-01815.
    >> Share

    June 2021
  2. MATSUHASHI T, Hatta W, Hikichi T, Fukuda S, et al
    A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding.
    J Gastroenterol. 2021 Jun 18. pii: 10.1007/s00535-021-01797.
    >> Share

    February 2021
  3. KAMADA T, Satoh K, Itoh T, Ito M, et al
    Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
    J Gastroenterol. 2021 Feb 23. pii: 10.1007/s00535-021-01769.
    >> Share

  4. LAI SW
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 5. pii: 10.1007/s00535-021-01764.
    >> Share

  5. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 2. pii: 10.1007/s00535-021-01761.
    >> Share

    November 2020
  6. IBANEZ-SANZ G, Mila N, de la Pena-Negro LC, Garcia M, et al
    Proton-pump inhibitors are associated with a high false-positivity rate in faecal immunochemical testing.
    J Gastroenterol. 2020 Nov 7. pii: 10.1007/s00535-020-01738.
    >> Share

  7. ROGERS B, Samanta S, Ghobadi K, Patel A, et al
    Artificial intelligence automates and augments baseline impedance measurements from pH-impedance studies in gastroesophageal reflux disease.
    J Gastroenterol. 2020 Nov 5. pii: 10.1007/s00535-020-01743.
    >> Share

    September 2020
  8. OKUBO H, Akiyama J, Kobayakawa M, Kawazoe M, et al
    Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility.
    J Gastroenterol. 2020 Sep 15. pii: 10.1007/s00535-020-01723.
    >> Share

    August 2020
  9. SAWADA A, Itami H, Nakagawa K, Hirano S, et al
    Supragastric belching in Japan: lower prevalence and relevance for management of gastroesophageal reflux disease compared to United Kingdom.
    J Gastroenterol. 2020 Aug 24. pii: 10.1007/s00535-020-01720.
    >> Share

    April 2020
  10. MASUDA K, Urabe Y, Ito M, Ono A, et al
    Correction to: Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradication therapy.
    J Gastroenterol. 2020 Apr 19. pii: 10.1007/s00535-020-01688.
    >> Share

    February 2020
  11. SUGIMOTO M, Murata M, Kawai T
    How long should patients be surveyed for gastric cancer risk after Helicobacter pylori eradication therapy? 10 years is no longer enough.
    J Gastroenterol. 2020 Feb 5. pii: 10.1007/s00535-020-01674.
    >> Share

    January 2020
  12. OSHIMA T, Wu L, Li M, Fukui H, et al
    Correction to: Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
    J Gastroenterol. 2020 Jan 30. pii: 10.1007/s00535-020-01671.
    >> Share

    December 2019
  13. TAKE S, Mizuno M, Ishiki K, Kusumoto C, et al
    Correction to: Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication.
    J Gastroenterol. 2019 Dec 9. pii: 10.1007/s00535-019-01654.
    >> Share

  14. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden.
    J Gastroenterol. 2019 Dec 6. pii: 10.1007/s00535-019-01652.
    >> Share

    October 2019
  15. TAKE S, Mizuno M, Ishiki K, Kusumoto C, et al
    Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication.
    J Gastroenterol. 2019 Oct 30. pii: 10.1007/s00535-019-01639.
    >> Share

    August 2019
  16. YOKOYA Y, Igarashi A, Uda A, Deguchi H, et al
    Cost-utility analysis of a 'vonoprazan-first' strategy versus 'esomeprazole- or rabeprazole-first' strategy in GERD.
    J Gastroenterol. 2019 Aug 8. pii: 10.1007/s00535-019-01609.
    >> Share

    June 2019
  17. MASUDA K, Urabe Y, Ito M, Ono A, et al
    Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradiation therapy.
    J Gastroenterol. 2019 Jun 13. pii: 10.1007/s00535-019-01596.
    >> Share

  18. PARK YH, Seong JM, Cho S, Han HW, et al
    Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study.
    J Gastroenterol. 2019 Jun 11. pii: 10.1007/s00535-019-01598.
    >> Share

    May 2019
  19. ANSARI S, Akada J, Matsuo Y, Shiota S, et al
    Epitope peptides of Helicobacter pylori CagA antibodies from sera by whole-peptide mapping.
    J Gastroenterol. 2019 May 2. pii: 10.1007/s00535-019-01584.
    >> Share

    April 2019
  20. TAKEUCHI T, Hongo H, Kimura T, Kojima Y, et al
    Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
    J Gastroenterol. 2019 Apr 29. pii: 10.1007/s00535-019-01588.
    >> Share

  21. SUGAWARA K, Koizumi S, Horikawa Y, Mimori N, et al
    Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan.
    J Gastroenterol. 2019 Apr 29. pii: 10.1007/s00535-019-01587.
    >> Share

    March 2019
  22. MIWA H, Igarashi A, Teng L, Uda A, et al
    Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease.
    J Gastroenterol. 2019 Mar 27. pii: 10.1007/s00535-019-01572.
    >> Share

  23. ISSHI K, Matsuhashi N, Joh T, Higuchi K, et al
    Correction to: Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
    J Gastroenterol. 2019 Mar 11. pii: 10.1007/s00535-019-01557.
    >> Share

    February 2019
  24. KAKIUCHI T, Matsuo M, Endo H, Nakayama A, et al
    A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report.
    J Gastroenterol. 2019 Feb 15. pii: 10.1007/s00535-019-01559.
    >> Share

    January 2019
  25. ISSHI K, Matsuhashi N, Joh T, Higuchi K, et al
    Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
    J Gastroenterol. 2019 Jan 23. pii: 10.1007/s00535-019-01546.
    >> Share

    September 2018
  26. XIAO S, Li S, Zhou L, Jiang W, et al
    Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis.
    J Gastroenterol. 2018 Sep 24. pii: 10.1007/s00535-018-1513.
    >> Share

    June 2018
  27. HAMADA K, Uedo N, Tonai Y, Arao M, et al
    Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study.
    J Gastroenterol. 2018 Jun 25. pii: 10.1007/s00535-018-1487.
    >> Share

    March 2018
  28. PONZETTO A, Figura N
    Gastric cancer prevention and Helicobacter pylori.
    J Gastroenterol. 2018 Mar 29. pii: 10.1007/s00535-018-1453.
    >> Share

    November 2017
  29. KINOSHITA Y, Kato M, Fujishiro M, Masuyama H, et al
    Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
    J Gastroenterol. 2017 Nov 29. pii: 10.1007/s00535-017-1417.
    >> Share

  30. KUSANO C, Gotoda T, Suzuki S, Ikehara H, et al
    Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children.
    J Gastroenterol. 2017 Nov 7. doi: 10.1007/s00535-017-1406.
    >> Share

    September 2017
  31. IMPERATORE N, Tortora R, Testa A, Gerbino N, et al
    Erratum to: Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet.
    J Gastroenterol. 2017 Sep 19. doi: 10.1007/s00535-017-1393.
    >> Share

    August 2017
  32. IMPERATORE N, Tortora R, Anna T, Gerbino N, et al
    Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet.
    J Gastroenterol. 2017 Aug 19. doi: 10.1007/s00535-017-1381.
    >> Share

  33. SU T, Lai S, Lee A, He X, et al
    Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
    J Gastroenterol. 2017 Aug 2. doi: 10.1007/s00535-017-1371.
    >> Share

    July 2017
  34. OSHIMA T, Wu L, Li M, Fukui H, et al
    Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
    J Gastroenterol. 2017 Jul 25. doi: 10.1007/s00535-017-1369.
    >> Share

    April 2017
  35. KIM TJ, Sinn DH, Min YW, Son HJ, et al
    A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
    J Gastroenterol. 2017 Apr 5. doi: 10.1007/s00535-017-1337.
    >> Share

    February 2017
  36. KUSANO M, Hosaka H, Yasuoka H, Kawamura O, et al
    New endoscopic classification of cascade stomach, a risk factor for reflux esophagitis.
    J Gastroenterol. 2017;52:211-217.
    >> Share

    January 2017
  37. HORIUCHI Y, Fujisaki J, Yamamoto N, Omae M, et al
    Diagnostic accuracy of demarcation of undifferentiated-type early gastric cancer after Helicobacter pylori eradication.
    J Gastroenterol. 2017 Jan 12. doi: 10.1007/s00535-017-1307.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016